IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 149 filers reported holding IMPAX LABORATORIES INC in Q2 2013. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $29,999,000 | -4.7% | 1,542,410 | -18.5% | 0.01% | 0.0% |
| Q4 2017 | $31,494,000 | -10.8% | 1,891,554 | +8.8% | 0.01% | -15.4% |
| Q3 2017 | $35,292,000 | +205.2% | 1,738,517 | +142.1% | 0.01% | +225.0% |
| Q2 2017 | $11,563,000 | -68.7% | 718,225 | -75.4% | 0.00% | -66.7% |
| Q1 2017 | $36,970,000 | -30.9% | 2,922,492 | -27.6% | 0.01% | -33.3% |
| Q4 2016 | $53,510,000 | -41.6% | 4,038,460 | +4.4% | 0.02% | -41.9% |
| Q3 2016 | $91,675,000 | -6.5% | 3,868,146 | +13.7% | 0.03% | -13.9% |
| Q2 2016 | $98,029,000 | -11.2% | 3,401,416 | -1.3% | 0.04% | -20.0% |
| Q1 2016 | $110,404,000 | -26.8% | 3,447,963 | -2.3% | 0.04% | -25.0% |
| Q4 2015 | $150,891,000 | +36.5% | 3,528,784 | +12.4% | 0.06% | +27.7% |
| Q3 2015 | $110,559,000 | -21.5% | 3,140,020 | +2.4% | 0.05% | -14.5% |
| Q2 2015 | $140,879,000 | -9.8% | 3,067,923 | -8.0% | 0.06% | -8.3% |
| Q1 2015 | $156,246,000 | +49.2% | 3,333,612 | +0.8% | 0.06% | +50.0% |
| Q4 2014 | $104,731,000 | +23.5% | 3,305,949 | -7.5% | 0.04% | +17.6% |
| Q3 2014 | $84,777,000 | -11.5% | 3,575,594 | +12.0% | 0.03% | -10.5% |
| Q2 2014 | $95,765,000 | +118.8% | 3,193,231 | +92.7% | 0.04% | +111.1% |
| Q1 2014 | $43,770,000 | +26.5% | 1,656,674 | +20.4% | 0.02% | +28.6% |
| Q4 2013 | $34,592,000 | +34.0% | 1,375,966 | +9.1% | 0.01% | +27.3% |
| Q3 2013 | $25,818,000 | +35.1% | 1,261,286 | +31.6% | 0.01% | +22.2% |
| Q2 2013 | $19,115,000 | – | 958,720 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |